Product Code: SR112023A4391
Abstract
The global fermenters market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2022-2028.
Fermenters, also known as stirred-tank bioreactors, are small, economical, sterilized process vessels used to cultivate heterotrophic microalgae. They use probes, sensors, and controlled clean-in-place systems to monitor conditions and maintain optimal levels of microbial growth. At present, they are utilized to manufacture a broad range of products, such as vinegar, cellulose, ethanol, protease, lipase, amylase, streptomycin, citric acid, lactic acid, and glutamic acid. These products find extensive applications in the pulp and paper production, biological wastewater treatment, and industrial solvents worldwide.
Fermenters Market Trends:
Fermenters can produce large yields quickly, tolerate unusual growth conditions like acidic or high temperatures and be genetically modified. As a result, they are widely utilized in the pharmaceutical industry to produce a wide range of chemical compounds, enzymes, and drugs. The escalating demand for these drugs on account of the rising prevalence of infectious and chronic diseases represents one of the major factors influencing the market positively. Apart from this, the fermentation process destroys harmful microorganisms and chemicals and adds beneficial bacteria that aids in digestion. As a result, fermenters are finding applications in the food and beverage (F&B) industry to preserve and alter the texture of soy products, dairy items, grains, and vegetables. Moreover, the increasing awareness among individuals about the health benefits of consuming fermented food products, which include improving the intestinal tract, immune system, and bioavailability of nutrients, and reducing the chances of lactose intolerance, allergy, and cancers, is contributing to market growth. Furthermore, fermenters can be incorporated with advanced technologies to facilitate process monitoring, data acquisition and storage, error detection, filtering, unit conversion, and measurement calculations, which is impelling the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global fermenters market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on process, mode of operation, material and end user.
Breakup by Process:
Batch
Fed-Batch
Continuous
Breakup by Mode of Operation:
Semi-Automatic
Automatic
Breakup by Material:
Stainless-Steel
Glass
Breakup by End User:
Food and Beverages
Pharmaceutical
Personal Care
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Applikon Biotechnology B.V. (Getinge AB), bbi-biotech GmbH, Bioengineering AG, CerCell A/S, Electrolab Biotech Ltd, GEA Group Aktiengesellschaft, General Electric Company, Pierre Guerin SAS (ENGIE Group Company), Sartorius AG, Thermo Fisher Scientific Inc. and ZETA Holding GmbH.
Key Questions Answered in This Report:
- How has the global fermenters market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global fermenters market?
- What are the key regional markets?
- What is the breakup of the market based on the process?
- What is the breakup of the market based on the mode of operation?
- What is the breakup of the market based on the material?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global fermenters market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Fermenters Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Process
- 6.1 Batch
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Fed-Batch
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Continuous
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Mode of Operation
- 7.1 Semi-Automatic
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Automatic
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Material
- 8.1 Stainless-Steel
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Glass
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End User
- 9.1 Food and Beverages
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Pharmaceutical
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Personal Care
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Applikon Biotechnology B.V. (Getinge AB)
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 bbi-biotech GmbH
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Bioengineering AG
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 CerCell A/S
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Electrolab Biotech Ltd
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 GEA Group Aktiengesellschaft
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 General Electric Company
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Pierre Guerin SAS (ENGIE Group Company)
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Sartorius AG
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Thermo Fisher Scientific Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 ZETA Holding GmbH
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio